CZR

Caesars Entertainment, Inc.

52
Fundamentals46/ 100
Valuation50/ 100
Upside potential56/ 100
Risk potential21/ 100

CZR has lower modeled downside risk, despite its lower overall score.

RIVN

Rivian Automotive, Inc.

53
Fundamentals56/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential31/ 100

RIVN has a slight edge over CZR overall, supported by stronger fundamentals and stronger modeled upside.

CZR Fundamentals

MetricStatus
Stable
Under pressure
Healthy
Under pressure

CZR's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.

RIVN Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

CZR PE Valuation

CZR has no meaningful PE right now: it lost money over the past year.

RIVN PE Valuation

RIVN has no meaningful PE right now: it lost money over the past year.

CZR Forward outlook

MetricOutlook
--
Losses growing
Stable
Weakening
Limited
Low

Analysts expect CZR's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.

RIVN Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

RIVN has the edge over CZR on the outlook, with more favorable earnings and revenue expectations.

CZR Risk to reward

ScenarioChangePrice
Upside+27%$37.12
Downside-21%$23.14

Calculated from the latest close: $29.28 on Nov 12.

CZR trails RIVN on modeled risk to reward, with less potential upside relative to its potential downside.

RIVN Risk to reward

ScenarioChangePrice
Upside+49%$19.04
Downside-31%$8.82

Calculated from the latest close: $12.80 on Nov 12.

RIVN has a better modeled risk to reward balance than CZR, with more potential upside relative to its potential downside.

CZR Earnings Per Share

Q4 2023: $3.64Q1 2024: $3.54Q2 2024: $-1.28Q3 2024: $-1.66Q4 2024: $-1.29Q1 2025: $-1.10Q2 2025: $-0.93Q3 2025: $-1.16Q4 2025: $-2.42Q1 2026: $-2.36Q2 2026: $-2.27Q3 2026: $-2.61
Q4 2023: $3.64Q1 2024: $3.54Q2 2024: $-1.28Q3 2024: $-1.66Q4 2024: $-1.29Q1 2025: $-1.10Q2 2025: $-0.93Q3 2025: $-1.16Q4 2025: $-2.42Q1 2026: $-2.36Q2 2026: $-2.27Q3 2026: $-2.61
QuarterTTM EPSYoY
Q3 2026-$2.61-$1.45
Q2 2026-$2.27-$1.34
Q1 2026-$2.36-$1.26
Q4 2025-$2.42-$1.13
Q3 2025-$1.16+$0.50
Q2 2025-$0.93+$0.35
Q1 2025-$1.10-131%
Q4 2024-$1.29-135%

CZR is still losing money, but far less than before: $2.61 per share over the past year, against $13.50 at its worst in late 2020.

RIVN Earnings Per Share

Q4 2023: $-5.74Q1 2024: $-5.77Q2 2024: $-5.96Q3 2024: $-5.60Q4 2024: $-4.69Q1 2025: $-3.69Q2 2025: $-3.20Q3 2025: $-3.08Q4 2025: $-3.07Q1 2026: $-2.92Q2 2026: $-2.58Q3 2026: $-2.25
Q4 2023: $-5.74Q1 2024: $-5.77Q2 2024: $-5.96Q3 2024: $-5.60Q4 2024: $-4.69Q1 2025: $-3.69Q2 2025: $-3.20Q3 2025: $-3.08Q4 2025: $-3.07Q1 2026: $-2.92Q2 2026: $-2.58Q3 2026: $-2.25
QuarterTTM EPSYoY
Q3 2026-$2.25+$0.83
Q2 2026-$2.58+$0.62
Q1 2026-$2.92+$0.77
Q4 2025-$3.07+$1.62
Q3 2025-$3.08+$2.52
Q2 2025-$3.20+$2.76
Q1 2025-$3.69+$2.08
Q4 2024-$4.69+$1.05

RIVN has the edge over CZR on earnings, with more consistent year-over-year improvement.

CZR Quarterly Revenue

Q4 2023: $2.8BQ1 2024: $2.7BQ2 2024: $2.8BQ3 2024: $2.9BQ4 2024: $2.8BQ1 2025: $2.8BQ2 2025: $2.9BQ3 2025: $2.9BQ4 2025: $2.9BQ1 2026: $2.9BQ2 2026: $3BQ3 2026: $2.9B
Q4 2023: $2.8BQ1 2024: $2.7BQ2 2024: $2.8BQ3 2024: $2.9BQ4 2024: $2.8BQ1 2025: $2.8BQ2 2025: $2.9BQ3 2025: $2.9BQ4 2025: $2.9BQ1 2026: $2.9BQ2 2026: $3BQ3 2026: $2.9B
QuarterRevenueYoY
Q3 2026$2.9B+2.5%
Q2 2026$3B+3%
Q1 2026$2.9B+2.7%
Q4 2025$2.9B+4.2%
Q3 2025$2.9B-0.2%
Q2 2025$2.9B+2.7%
Q1 2025$2.8B+1.9%
Q4 2024$2.8B-0.9%

CZR's revenue grew through 2022 and has held roughly level since: $2.9B last quarter, up 2.5% from the same quarter a year ago.

RIVN Quarterly Revenue

Q4 2023: $1.3BQ1 2024: $1.2BQ2 2024: $1.2BQ3 2024: $874MQ4 2024: $1.7BQ1 2025: $1.2BQ2 2025: $1.3BQ3 2025: $1.6BQ4 2025: $1.3BQ1 2026: $1.4BQ2 2026: $1.7BQ3 2026: $2.2B
Q4 2023: $1.3BQ1 2024: $1.2BQ2 2024: $1.2BQ3 2024: $874MQ4 2024: $1.7BQ1 2025: $1.2BQ2 2025: $1.3BQ3 2025: $1.6BQ4 2025: $1.3BQ1 2026: $1.4BQ2 2026: $1.7BQ3 2026: $2.2B
QuarterRevenueYoY
Q3 2026$2.2B+38%
Q2 2026$1.7B+27%
Q1 2026$1.4B+11%
Q4 2025$1.3B-26%
Q3 2025$1.6B+78%
Q2 2025$1.3B+13%
Q1 2025$1.2B+3%
Q4 2024$1.7B+32%

RIVN has the edge over CZR on sales, with more consistent year-over-year improvement.

CZR Free Cash Flow

Q4 2023: $139MQ1 2024: −$184MQ2 2024: $125MQ3 2024: −$192MQ4 2024: $30MQ1 2025: −$5MQ2 2025: $232MQ3 2025: $123MQ4 2025: $147MQ1 2026: $36MQ2 2026: $304MQ3 2026: $95M
Q4 2023: $139MQ1 2024: −$184MQ2 2024: $125MQ3 2024: −$192MQ4 2024: $30MQ1 2025: −$5MQ2 2025: $232MQ3 2025: $123MQ4 2025: $147MQ1 2026: $36MQ2 2026: $304MQ3 2026: $95M
QuarterFree cash flowYoY
Q3 2026$95M-23%
Q2 2026$304M+31%
Q1 2026$36M+$41M
Q4 2025$147M+390%
Q3 2025$123M+$315M
Q2 2025$232M+86%
Q1 2025-$5M+$179M
Q4 2024$30M-78%

CZR has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.

RIVN Free Cash Flow

Q4 2023: −$1.4BQ1 2024: −$1.5BQ2 2024: −$1BQ3 2024: −$1.2BQ4 2024: $856MQ1 2025: −$526MQ2 2025: −$398MQ3 2025: −$421MQ4 2025: −$1.1BQ1 2026: −$1.1BQ2 2026: −$849MQ3 2026: −$1.1B
Q4 2023: −$1.4BQ1 2024: −$1.5BQ2 2024: −$1BQ3 2024: −$1.2BQ4 2024: $856MQ1 2025: −$526MQ2 2025: −$398MQ3 2025: −$421MQ4 2025: −$1.1BQ1 2026: −$1.1BQ2 2026: −$849MQ3 2026: −$1.1B
QuarterFree cash flowYoY
Q3 2026-$1.1B-$703M
Q2 2026-$849M-$451M
Q1 2026-$1.1B-$549M
Q4 2025-$1.1B-234%
Q3 2025-$421M+$732M
Q2 2025-$398M+$639M
Q1 2025-$526M+$997M
Q4 2024$856M+$2.3B

RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.

CZR Total Shares

Q4 2023: 216MQ1 2024: 216MQ2 2024: 216MQ3 2024: 215MQ4 2024: 215MQ1 2025: 212MQ2 2025: 209MQ3 2025: 207MQ4 2025: 208MQ1 2026: 204MQ2 2026: 204MQ3 2026: 204M
Q4 2023: 216MQ1 2024: 216MQ2 2024: 216MQ3 2024: 215MQ4 2024: 215MQ1 2025: 212MQ2 2025: 209MQ3 2025: 207MQ4 2025: 208MQ1 2026: 204MQ2 2026: 204MQ3 2026: 204M
PeriodChange %Net change
Quarterly0%--
1 year-1.4%-3M shares
3 years-5.6%-12M shares
5 years-4.7%-10M shares
Available history+162%+126M shares

CZR has the edge over RIVN on shareholder dilution, with a more favorable share count trend.

RIVN Total Shares

Q4 2023: 947MQ1 2024: 978MQ2 2024: 1BQ3 2024: 1BQ4 2024: 1BQ1 2025: 1.1BQ2 2025: 1.2BQ3 2025: 1.2BQ4 2025: 1.2BQ1 2026: 1.2BQ2 2026: 1.3BQ3 2026: 1.4B
Q4 2023: 947MQ1 2024: 978MQ2 2024: 1BQ3 2024: 1BQ4 2024: 1BQ1 2025: 1.1BQ2 2025: 1.2BQ3 2025: 1.2BQ4 2025: 1.2BQ1 2026: 1.2BQ2 2026: 1.3BQ3 2026: 1.4B
PeriodChange %Net change
Quarterly+9.1%+121M shares
1 year+19%+226M shares
3 years+52%+494M shares

RIVN has 1.4B diluted shares, up 19% from a year ago.

CZR Net Leverage

Q4 2023: 3.0xQ1 2024: 3.2xQ2 2024: 3.2xQ3 2024: 3.4xQ4 2024: 3.1xQ1 2025: 3.1xQ2 2025: 3.0xQ3 2025: 3.0xQ4 2025: 3.3xQ1 2026: 3.3xQ2 2026: 3.3xQ3 2026: 3.3x
Q4 2023: 3.0xQ1 2024: 3.2xQ2 2024: 3.2xQ3 2024: 3.4xQ4 2024: 3.1xQ1 2025: 3.1xQ2 2025: 3.0xQ3 2025: 3.0xQ4 2025: 3.3xQ1 2026: 3.3xQ2 2026: 3.3xQ3 2026: 3.3x
QuarterNet LeverageStatus
Q3 20263.3xElevated
Q2 20263.3xElevated
Q1 20263.3xElevated
Q4 20253.3xElevated
Q3 20253.0xElevated
Q2 20253.0xElevated
Q1 20253.1xElevated
Q4 20243.1xElevated

CZR's net debt is about 3.3 years of its operating earnings (EBITDA), up from 3.0 years a year ago.

RIVN Net Leverage

RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CZR Weekly Momentum

MetricValueStatus
RSI54.5Neutral
Stochastic38.6Neutral

CZR's weekly RSI is 55 (neutral) and its Stochastic is 39 (neutral).

RIVN Weekly Momentum

MetricValueStatus
RSI41.5Neutral
Stochastic25.6Neutral

RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).

CZR PE vs Consumer Cyclical Sector

MetricCZRSector medianRelative
PEN/A18x—

CZR has no meaningful PE right now: it lost money over the past year.

RIVN PE vs Consumer Cyclical Sector

RIVN has no meaningful PE right now: it lost money over the past year.

CZR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.20.1% above
20 week MA$29.61.1% below
50 week MA$27.37.2% above
100 week MA$27.66.3% above
200 week MA$35.718% below

CZR has the edge over RIVN on trend strength, trading above more of its moving averages.

RIVN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$13.33.9% below
20 week MA$15.115% below
50 week MA$15.919% below
100 week MA$14.713% below
200 week MA$15.115% below

RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.

CZR Yearly ROI

YearStart priceEnd priceROI
2020$59.2$75.8+28%
2021$75.8$94.8+25%
2022$94.8$43.1-55%
2023$43.1$46.9+8.8%
2024$46.9$33.1-29%
2025$33.1$24.8-25%
2026 YTD$24.8$29.3+18%

CZR has the edge over RIVN on returns for 2026, with the stronger performance.

RIVN Yearly ROI

YearStart priceEnd priceROI
2021$130.0$96.8-25%
2022$96.8$19.1-80%
2023$19.1$23.5+23%
2024$23.5$13.7-42%
2025$13.7$20.9+53%
2026 YTD$20.9$12.8-39%

RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.

Give your agent the market.

Get API key